Navigating Access, Cost, and Education in Multiple Sclerosis Treatment

Aimee Banks, PharmD, BCPS, MSCS, discusses how access to care remains one of the biggest challenges for patients living with multiple sclerosis. She explains that barriers often begin with limited access to specialized neurologists who can confirm diagnoses and guide treatment decisions. Even when clinically appropriate therapies are recommended, high costs, insurance denials, and prior authorization requirements can delay or limit access to care. Banks emphasizes that patient education is essential, ensuring individuals understand their diagnosis, treatment options, and associated risks and benefits. She also highlights the critical role pharmacists play as liaisons, working with providers, insurers, and financial assistance programs to help patients overcome logistical and financial barriers to treatment.